Tagged multi-nucleotides useful for nucleic acid sequencing

Patent metadata

Field	Value
Publication number	US-10975432-B2
Application number	US-202016822802-A
Country	US
Kind code	B2
Filing date	Mar 18, 2020
Priority date	May 27, 2016
Publication date	Apr 13, 2021
Grant date	Apr 13, 2021

Abstract

The present disclosure relates to tagged multi-nucleotide compounds, which comprise a single tag moiety covalently linked to a plurality of nucleoside-5′-oligophosphate moieties. As disclosed herein, these tagged multi-nucleotide compounds have improved characteristics as polymerase substrates and can be used in a range of nucleic acid detection and sequencing methods, including nanopore sequencing-by-synthesis.

First claim

What is claimed is:

1. A method for determining the sequence of a nucleic acid comprising:
(a) providing a nanopore sequencing composition comprising: a membrane, an electrode on the cis side and the trans side of the membrane, a nanopore with its pore extending through the membrane, an electrolyte solution in contact with both electrodes, an active polymerase situated adjacent to the nanopore, and a primer strand complexed with the polymerase;
(b) contacting the nanopore sequencing composition with (i) a strand of the nucleic acid; and (ii) a set of compounds each comprising a single tag covalently linked to a plurality of nucleoside-5′-oligophosphate moieties, wherein the tag is a molecular moiety selected from a polyethylene-glycol (PEG) oligomer, an oligonucleotide comprising natural and/or non-natural analog monomer units, a polypeptide comprising natural and/or non-natural analog monomer units, and an oligomeric moiety comprising a combination of any of these and is capable of producing a detectable signal, each nucleoside-5′-oligophosphate moiety is capable of being a substrate for a polymerase, and each member of the set of compounds has a different tag that produces a different detectable signal when the tag is situated in a nanopore; and
(c) detecting the different detectable signals of the tags over time and correlating to each of the different tags the different compounds incorporated by the polymerase which are complementary to the nucleic acid sequence, and thereby determining the nucleic acid sequence.

2. The method of claim 1 , wherein each compound of the set has a structural formula (I)
[N-P-L] m -T   (I)

wherein,
N is a nucleoside;
P is an oligophosphate covalently attached to a 5′—O group of the nucleoside, wherein the oligophosphate consists of 3 to 12 phosphate groups;
L is a linker covalently attached to a terminal phosphate group of the oligophosphate;
m is from 2 to 12 and indicates the number of N-P-L moieties; and
T is the tag covalently attached the N-P-L moieties.

3. The method of claim 2 , wherein m is from 2 to 6.

4. The method of claim 1 , wherein each compound of the set has structural formula (II)

wherein,
Base is selected from adenosine, cytidine, guanosine, thymidine, and uridine;
R is selected from H and OH;
n is from 1 to 4;
Linker is a linker comprising a covalently bonded chain of 2 to 100 atoms;
m is from 2 to 12; and
Tag is the tag.

5. The method of claim 4 , wherein m is from 2 to 6.

6. The method of claim 4 , wherein the linker comprises a chemical group having structural formula (XVd) or (XVe):

7. The method of claim 1 , wherein each compound of the set has a structural formula selected from formula (IIIa), (IIIb), or (IIIc):

wherein,
Base is selected from adenosine, cytidine, guanosine, thymidine, and uridine;
R is selected from H and OH;
n is from 1 to 4;
Linker is a linker comprising a covalently bonded chain of 2 to 100 atoms; and
Tag is the tag.

8. The method of claim 3 , wherein the linker comprises a chemical group having structural formula (XVd) or (XVe):

9. The method of claim 1 , wherein each compound has a structural formula selected from formula (IIId), (IIIe), or (IIIf):

wherein,
Base is selected from adenosine, cytidine, guanosine, thymidine, and uridine;
R is selected from H and OH;
n is from 1 to 4;
p is from 2 to 10; and
Tag is the tag.

10. The method of claim 1 , wherein at least one of the different tags comprises an oligonucleotide having a monomer unit length of from 15-mer to 45-mer.

11. The method of claim 1 , wherein at least one of the different tags comprises an oligonucleotide having a structure selected from Table 3, 7, 8, or 10, or a sequence selected from SEQ ID NO: 1-109.

12. The method of claim 1 , wherein at least one of the different tags comprises a polypeptide.

13. The method of claim 1 , wherein at least one of the different tags comprises a polypeptide having a structure selected from Table 5, or a sequence selected from SEQ ID NO: 110-123.

14. The method of claim 1 , wherein the linker comprises a chemical group selected from the group consisting of: ester, ether, thioether, amine, amide, imide, benzene, benzyl ether, phenol, bis-hydroxyethylbenzene, carbonate, carbamate, squarate, thiazole, thiazolidine, hydrazone, oxime, triazole, dihydropyridazine, phosphodiester, polyethylene glycol (PEG), and combinations thereof.

15. The method of claim 1 , wherein the detectable signals produced by at least two compounds of the set differ by at least 10%, at least 25%, at least 50%, or at least 75%.

16. The method of claim 1 , wherein the set of compounds comprises (dA6P) 2 -dT 5 -(BHEB)-dT 14 -C3; (dC6P) 2 -dT 20 -C3; (dT 6 P) 2 -dT 4 -(N3CE-dT) 3 -dT 13 -C3; and (dG6P) 2 -dT 6 -(Tmp) 6 -dT 8 -C3.

17. The method of claim 1 , wherein the set of compounds comprises (dA6P) 2 -dT 4 -(idSp-dT) 4 -dT 8 -C3; (dC6P) 2 -dT 20 -C3; (dT 6 P) 2 -dT 4 -(N3CE-dT) 3 -dT 13l -C 3; and (dG6P) 2 -dT 6 -(Tmp) 6 -dT 8 -C3.

Assignees

• Roche Sequencing Solutions Inc

Inventors

• Gremyachinskiy Dmitriy
• Taing Meng
• AYER Aruna
• Crisalli Peter J

Classifications

• G01N33/48721

  Investigating individual macromolecules, e.g. by translocation through nanopores (Coulter counters in general G01N15/12; fabrication methods for nanoscale apertures B81B1/00; sequencing of nucleic acids C12Q1/68) · CPC title

• C07H19/10

  with the saccharide radical esterified by phosphoric or polyphosphoric acids · CPC title

• C12Q1/6874 Primary

  involving nucleic acid arrays, e.g. sequencing by hybridisation · CPC title

• G01N27/44791

  Microapparatus (sample containers with integrated microfluidic structures B01L3/5027) · CPC title

• C12Q2535/122

  Massive parallel sequencing · CPC title